Alpha 2.0
Login Register
» Authors » Tugba Arikoglu

Tugba Arikoglu

Explore the profile of Tugba Arikoglu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 32
Citations 119
Followers 0
Related Specialties
Allergy & Immunology
Pediatrics
Pulmonary Medicine
Top 10 Co-Authors
Semanur Kuyucu
Aylin Kont Ozhan
Ali Demirhan
Sehra Birgul Batmaz
Ayca Kiykim
Ahmet Ozen
Safa Baris
Didem Derici Yildirim
Ilhan Tezcan
Sara Sebnem Kilic
Published In
Allergy Asthma Proc
J Clin Immunol
Pediatr Hematol Oncol
Int J Clin Pharm
Curr Pharm Des
Affiliations
Soon will be listed here.
Recent Articles
1.
Evaluation of drug-related anaphylaxis in children: multi-center study
Metbulut A, Haci I, Can D, Bekis Bozkurt H, Cavkaytar O, Arga M, et al.
Eur J Pediatr . 2025 Mar; 184(3):230. PMID: 40053151
The aim of the study is to elucidate demographic characteristics, risk factors, clinical presentations, causative agents, and management approaches pertaining to drug-related anaphylaxis in the paediatric population. This study is...
2.
Correction to: Genetic Evaluation of the Patients with Clinically Diagnosed Inborn Errors of Immunity by Whole Exome Sequencing: Results from a Specialized Research Center for Immunodeficiency in Türkiye
Erman B, Aba U, Ipsir C, Pehlivan D, Aytekin C, Cildir G, et al.
J Clin Immunol . 2024 Nov; 45(1):41. PMID: 39540960
No abstract available.
3.
A single center experience on PI3K/AKT/MTOR signaling defects: Towards pathogenicity assessment for four novel defects
Bildik H, Esenboga S, Oskay Halacli S, Karaatmaca B, Soyak Aytekin E, Nabiyeva N, et al.
Pediatr Allergy Immunol . 2024 Sep; 35(9):e14245. PMID: 39312287
Background: Phosphoinositide 3 kinases (PI3K) are lipid kinases expressed in lymphocytes/myeloid cells. PI3K/AKT/mTOR signaling defects present with recurrent infections, autoimmunity, lymphoproliferation, and agammaglobulinemia. Objective: To characterize the PI3K/AKT/mTOR pathway defects...
4.
MHC Class II Deficiency: Clinical, Immunological, and Genetic Insights in a Large Multicenter Cohort
Gulec Koksal Z, Bilgic Eltan S, Topyildiz E, Sezer A, Keles S, Celebi Celik F, et al.
J Allergy Clin Immunol Pract . 2024 Jul; 12(9):2490-2502.e6. PMID: 38996837
Background: Major histocompatibility complex class II deficiency, a combined immunodeficiency, results from loss of HLA class II expression on antigen-presenting cells. Currently, hematopoietic stem cell transplantation stands as the sole...
5.
Genetic Evaluation of the Patients with Clinically Diagnosed Inborn Errors of Immunity by Whole Exome Sequencing: Results from a Specialized Research Center for Immunodeficiency in Türkiye
Erman B, Aba U, Ipsir C, Pehlivan D, Aytekin C, Cildir G, et al.
J Clin Immunol . 2024 Jul; 44(7):157. PMID: 38954121
Molecular diagnosis of inborn errors of immunity (IEI) plays a critical role in determining patients' long-term prognosis, treatment options, and genetic counseling. Over the past decade, the broader utilization of...
6.
Diagnostic evaluation of hypersensitivity reactions to arylpropionic acid derivatives: a descriptive observational study focusing on clinical characteristics and potential risk factors in children
Arikoglu T, Tokmeci N, Demirhan A, Ozhan A, Yalaki A, Akbey V, et al.
Int J Clin Pharm . 2024 Jun; 46(6):1294-1306. PMID: 38861048
Background: Arylpropionic acid derivatives (APs) are the main triggers of nonsteroidal anti-inflammatory drug (NSAID) hypersensitivity. Data on clinical patterns and risk factors for AP hypersensitivity in children are quite limited....
7.
Lower Arginine Bioavailability, Increased FeNO Levels, and Airway Resistance on Impulse Oscillometry Are Characteristics of Asthma in Children and Young Adults with Sickle Cell Disease
Ozhan A, Arikoglu T, Er M, Unal S, Yildirim D, Erkasar F, et al.
Medicina (Kaunas) . 2024 Mar; 60(3). PMID: 38541172
: Data on characteristics of asthma in children with sickle cell disease (SCD) is conflicting. Recently, the L-arginine pathway has gained attention in the pathogenesis of asthma and SCD. This...
8.
A Bayesian Network Meta-Analysis of the Effect of Targeted Therapies on the Total Length of Hospital Stay in Children with Drug-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Syndrome
Ozerturk S, Yildirim D, Arikoglu T, Kuyucu S, Ozhan A
Pediatr Allergy Immunol Pulmonol . 2024 Mar; 37(1):22-32. PMID: 38484271
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare potentially life-threatening hypersensitivity disorders characterized by widespread skin and mucosal involvement. However, there is no standardized evidence-based treatment to reduce...
9.
Evaluation of Pediatric Chronic Urticaria with Emphasis on Clinical and Laboratory Characteristics and Treatment Response to Omalizumab: A Real-Life Experience from a Tertiary Allergy Center
Ozhan A, Arikoglu T
Children (Basel) . 2024 Jan; 11(1). PMID: 38255399
Pediatric data on the clinical and etiologic features, treatment response, and use of omalizumab for chronic urticaria (CU) are quite limited. The aim of this study was to evaluate the...
10.
Toxic Skin Reactions Should Be Differentiated from Allergic Reactions to Chemotherapeutic Drugs in Children: A Case Series and Review of the Literature
Ozhan A, Demirhan A, Arikoglu T, Karahan F, Gokalp Satici F, Tokmeci N, et al.
Dermatitis . 2024 Jan; 35(3):275-287. PMID: 38165639
Chemotherapeutic drugs can lead to a wide spectrum of cutaneous findings, ranging from nonimmune toxic reactions to severe immune-mediated hypersensitivity reactions. The aim of this study was to evaluate the...